Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

NCT03826992 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Vyxeos
DRUG: Venetoclax

Sponsor

Children's Hospital Medical Center, Cincinnati